BTG (BTG)

Sector: Pharma and Biotech     Index: FTSE 250
2.83%
20.00p
727.00p
17:17 17/10/17
727.00p
17:17 17/10/17
DAILY VARIATION
2.83%
20.00p
VOLUME
1,385,101
REAL TIME BATS
723.50p
17:37 17/10/17
2.41%
17.00p
DATA
52 Week High
730.00p
52 Week Low
534.50p
Shares Issued
386.36m
Market Cap
£2,808.85m
RiskGrade
n/a
Beta
0.77
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 10.1% 23.3%
ROCE 24.7%
Latest F'cast
P/E 31.5 23.9
PEG 5.7 0.9
Pr/Revenue 4.9 4.6
Pr/Book 2.9
Latest F'cast
Revenue 27.5% -6.6%
PBT -45.0% n/a
EPS 5.5% -8.3%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%
2015-03-31 367.80 26.70 15.70p 45.5 5.5 8% n/a 0.0%
2016-03-31 447.50 57.50 21.90p 28.4 0.7 39% n/a 0.0%
2017-03-31 570.50 31.60 23.10p 25.4 4.6 5% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2018-03-31 593.94 138.53 29.36p 23.9 0.9 27% 0.00p 0.0%
2019-03-31 631.01 167.21 33.56p 21.2 1.5 14% 0.00p 0.0%

Regulatory News

slide to see more
Director Declaration 17-Oct-17 07:22
Close Period Update 05-Oct-17 07:06
BTG acquires Roxwood Medical 05-Oct-17 07:03